OpenVSafe by OpenVAERS
Search V-safe

A3N-77624-03511

2 vaccinations 5 coded responses 6 check-ins 5 free-text entries 0 call cases
Sex
Female
Age at first dose
41-45
ZIP prefix
404 / KY
Registered
2021-06-15
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino
Registered dependents
WBA-72245-42115 Child or adolescent in my care · Male · 2021-06-15
A4D-39432-47206 Adult relative or friend · Male · 2021-06-15
W52-30096-82829 Child or adolescent in my care · Male · 2021-06-15

Timeline

  1. 2021-05-14
    Dose 1 — Pfizer-BioNTech
  2. 2021-06-04
    Dose 2 — Pfizer-BioNTech
  3. 2021-06-15
    Registered in v-safe
  4. 2021-06-15
    Survey response — day 7, dose 2
    MedDRA: Injection site induration, Injection site mass — Feeling: Fair · Site: Swelling · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness
    Free text: Hard lump at injection site
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-06-18
    Survey response — day 14, dose 2
    MedDRA: Arthralgia, Headache, Myalgia — Feeling: Fair
    Free text: Headache , joint and muscle pain- worse in hip/pelvis and lower extremity but also in upper extremity just not as bad. Chilling
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-06-25
    Survey response — day 21, dose 2
    MedDRA: Arthralgia, Fatigue, Headache, Myalgia, Peripheral swelling — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Swelling of bilateral lower extremities, muscle joint pain, extreme fatigue, ongoing headache
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-07-02
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  8. 2021-07-13
    Survey response — day 35, dose 2
    MedDRA: Arthralgia, Myalgia, Nasal congestion, Respiratory tract congestion, Sinus congestion — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Reappearance of muscle and joint pain, fatigue. (Prevents exercise routine). New symptoms of head/sinus/nasal fullness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-07-16
    Survey response — day 42, dose 2
    MedDRA: Arthralgia, Headache, Myalgia — Feeling: Poor · Be unable to do your normal daily activities
    Free text: Extreme muscle and joint pain , worsening headaches
    MedDRA releases: 2021-09,2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-05-14Pfizer-BioNTech
22021-06-04Pfizer-BioNTech

Free text

Release 9 — day 7, dose 2

2021-06-15

Systemic reaction (other): Hard lump at injection site

Release 9 — day 14, dose 2

2021-06-18

Symptoms: Headache , joint and muscle pain- worse in hip/pelvis and lower extremity but also in upper extremity just not as bad. Chilling

Release 9 — day 21, dose 2

2021-06-25

Symptoms: Swelling of bilateral lower extremities, muscle joint pain, extreme fatigue, ongoing headache

Release 9 — day 35, dose 2

2021-07-13

Symptoms: Reappearance of muscle and joint pain, fatigue. (Prevents exercise routine). New symptoms of head/sinus/nasal fullness

Release 9 — day 42, dose 2

2021-07-16

Symptoms: Extreme muscle and joint pain , worsening headaches

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDArthralgia ✓ ✓ ✓
SDFatigue ✓ ✓ ✓
SDHeadache ✓ ✓ ✓
SDMyalgia ✓ ✓ ✓
SDNasal congestion ✓ ✓ ✓
SDPeripheral swelling ✓ ✓ ✓
SDRespiratory tract congestion ✓ ✓ ✓
SDSinus congestion ✓ ✓ ✓
SROInjection site induration ✓ ✓ ✓
SROInjection site mass ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release